Lv71
4610 积分 2024-03-07 加入
Metabolite Profiling and Identification of Semaglutide in Liver S9 Across Species and Rat Plasma
1个月前
已完结
Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration
6个月前
已完结
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
7个月前
已完结
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
9个月前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization towards orally available bifunctional protein degraders
9个月前
已完结
An update on the importance of plasma protein binding in drug discovery and development
9个月前
已完结
Bridging in vitro and clinical data: Experimental insights into the IC50 variability of dolutegravir as an organic cation transporter 2 inhibitor
10个月前
已关闭
Cerivastatin-induced rhabdomyolysis in a renal transplant on cyclosporin
10个月前
已关闭
皖公网安备34019202002308
